Always appreciate the feedback Ops, as well as from Saltz. I’m going to go back and listen to the tape again and see if there is something I missed.
A couple items that I left more confused with or felt Nader didn’t just “answer” the question:
1) when asked about his stock sale, he mentioned his warrants and when asked if it all went to the company (paraphrasing), I didn’t get the sense of a clear “yes”. That type of wishy-washy mansplaining is what gets him in trouble.
2) his recitations of letters from patients seem too hokey for that type of call. I’d recommend putting copies of them as “testimonials” on the web site. When Nader reads them, I’m lost in the first 10 seconds.
3) why the need to talk about the first group of 11 severely critical patients and mentioned how many died? This has been discussed. I thought we would get some 14-day data from the first grouping but I don’t recall hearing about that.
4) the person hosting is AWFUL!! He’s unprepared and didn’t even know how to pronounce names. The questions were not screened and redundant..:that’s no fault of Nader’s BUT he lacks the foresight to do a mock run or set some ground rules. It was as bad as the Charles Payne interview where it was clear that Payne knew nothing and just winging it.
Again, lost opportunity
5). Now we get to the real issue: we don’t have a financial partner. We CAN NOT compete on the world stage without financial backing
6) the government is giving lesser proven therapies all the love while we get zip! That concerns me!
7) Nader clearly mentioned the PROBABILITY of 100+ millions shares being added. Two things to glean from this: Dilution and No Partner.
I’m totally on board with the science but as I’ve said for two years: Nader’s strengths (passion and he’s a bulldog) are far outweighed by his weaknesses: never brought a product to market, can’t find a partner, no juice with FDA, constant missed deadlines, mixed messaging, clarification of previous PR’s (BLA submission). He should have KNOWN and DISCLOSED that the process is fluid and while the BLA was submitted, it’s possible to receive requests from FDA. He doesn’t know the machinations of the process so he learns as he goes.
I can only go by what I see. And what I see are lesser drugs getting funding, partnerships, approval etc.
Nader is going to price us out of the market and I’m concerned we will be left behind.
Disclaimer: yes, I sold shares yesterday and have my purchase order in today for $2.85. It’s because I believe in the science that I’m willing to gamble to ADD shares. However, I’m not allowing myself to be naive that Nader might just not be able to pull it off.
Best of health to everyone! Whatever your investment philosophy is, I wish everyone the best. For me, I’ve already won! I bought down to $.30.
Sold and yes, had to buy back at a premium in December but have managed to acquire more. At one point, I said I’d take $2-3 and walk. I’m playing with house money!!
Let’s all get rich and save some lives!
Grip
